Evgenii Belykh1, Eric J Miller2, Arpan A Patel2, Mohammedhassan Izady Yazdanabadi2, Nikolay L Martirosyan2, Kaan Yağmurlu2, Baran Bozkurt2, Vadim A Byvaltsev3, Jennifer M Eschbacher2, Peter Nakaji2, Mark C Preul4. 1. Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA; Irkutsk State Medical University, Irkutsk, Russia. 2. Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA. 3. Irkutsk State Medical University, Irkutsk, Russia. 4. Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA. Electronic address: Neuropub@barrowneuro.org.
Abstract
OBJECTIVE: Glioma resection with fluorescein sodium (FNa) guidance has a potential drawback of nonspecific leakage of FNa from nontumor areas with a compromised blood-brain barrier. We investigated the diagnostic accuracy of in vivo confocal laser endomicroscopy (CLE) after FNa administration to differentiate normal brain, injured normal brain, and tumor tissue in an animal glioma model. METHODS: GL261-Luc2 gliomas in C57BL/6 mice were used as a brain tumor model. CLE images of normal, injured normal, and tumor brain tissues were collected after intravenous FNa administration. Correlative sections stained with hematoxylin and eosin were taken at the same sites. A set of 40 CLE images was given to 1 neuropathologist and 3 neurosurgeons to assess diagnostic accuracy and rate image quality (1-10 scale). Additionally, we developed a deep convolution neural network (DCNN) model for automatic image classification. RESULTS: The mean observer accuracy for correct diagnosis of glioma compared with either injured or uninjured brain using CLE images was 85%, and the DCNN model accuracy was 80%. For differentiation of tumor from nontumor tissue, the experts' mean accuracy, specificity, and sensitivity were 90%, 86%, and 96%, respectively, with high interobserver agreement overall (Cohen κ = 0.74). The percentage of correctly identified images was significantly higher for images with a quality rating >5 (104/116, 90%) than for images with a quality rating ≤5 (32/44, 73%) (P = 0.007). CONCLUSIONS: With sufficient FNa present in tissues, CLE was an effective tool for intraoperative differentiation among normal, injured normal, and tumor brain tissue. Clinical studies are warranted to confirm these findings.
OBJECTIVE:Glioma resection with fluorescein sodium (FNa) guidance has a potential drawback of nonspecific leakage of FNa from nontumor areas with a compromised blood-brain barrier. We investigated the diagnostic accuracy of in vivo confocal laser endomicroscopy (CLE) after FNa administration to differentiate normal brain, injured normal brain, and tumor tissue in an animal glioma model. METHODS: GL261-Luc2 gliomas in C57BL/6 mice were used as a brain tumor model. CLE images of normal, injured normal, and tumor brain tissues were collected after intravenous FNa administration. Correlative sections stained with hematoxylin and eosin were taken at the same sites. A set of 40 CLE images was given to 1 neuropathologist and 3 neurosurgeons to assess diagnostic accuracy and rate image quality (1-10 scale). Additionally, we developed a deep convolution neural network (DCNN) model for automatic image classification. RESULTS: The mean observer accuracy for correct diagnosis of glioma compared with either injured or uninjured brain using CLE images was 85%, and the DCNN model accuracy was 80%. For differentiation of tumor from nontumor tissue, the experts' mean accuracy, specificity, and sensitivity were 90%, 86%, and 96%, respectively, with high interobserver agreement overall (Cohen κ = 0.74). The percentage of correctly identified images was significantly higher for images with a quality rating >5 (104/116, 90%) than for images with a quality rating ≤5 (32/44, 73%) (P = 0.007). CONCLUSIONS: With sufficient FNa present in tissues, CLE was an effective tool for intraoperative differentiation among normal, injured normal, and tumor brain tissue. Clinical studies are warranted to confirm these findings.
Authors: Evgenii Belykh; Arpan A Patel; Eric J Miller; Baran Bozkurt; Kaan Yağmurlu; Eric C Woolf; Adrienne C Scheck; Jennifer M Eschbacher; Peter Nakaji; Mark C Preul Journal: Cancer Manag Res Date: 2018-08-30 Impact factor: 3.989
Authors: Evgenii Belykh; Xiaochun Zhao; Brandon Ngo; Dara S Farhadi; Vadim A Byvaltsev; Jennifer M Eschbacher; Peter Nakaji; Mark C Preul Journal: Front Oncol Date: 2020-12-04 Impact factor: 6.244
Authors: Francesco Acerbi; Bianca Pollo; Camilla De Laurentis; Francesco Restelli; Jacopo Falco; Ignazio G Vetrano; Morgan Broggi; Marco Schiariti; Irene Tramacere; Paolo Ferroli; Francesco DiMeco Journal: Front Oncol Date: 2020-12-23 Impact factor: 6.244
Authors: Irakliy Abramov; Alexander B Dru; Evgenii Belykh; Marian T Park; Liudmila Bardonova; Mark C Preul Journal: Front Oncol Date: 2021-09-30 Impact factor: 6.244
Authors: Yuan Xu; Irakliy Abramov; Evgenii Belykh; Giancarlo Mignucci-Jiménez; Marian T Park; Jennifer M Eschbacher; Mark C Preul Journal: Front Oncol Date: 2022-08-24 Impact factor: 5.738
Authors: Alexander J Schupper; Manasa Rao; Nicki Mohammadi; Rebecca Baron; John Y K Lee; Francesco Acerbi; Constantinos G Hadjipanayis Journal: Front Neurol Date: 2021-06-16 Impact factor: 4.003
Authors: Mohammadhassan Izadyyazdanabadi; Evgenii Belykh; Michael A Mooney; Jennifer M Eschbacher; Peter Nakaji; Yezhou Yang; Mark C Preul Journal: Front Oncol Date: 2018-07-03 Impact factor: 6.244
Authors: Evgenii Belykh; Naomi R Onaka; Xiaochun Zhao; Irakliy Abramov; Jennifer M Eschbacher; Peter Nakaji; Mark C Preul Journal: Front Neurol Date: 2021-07-16 Impact factor: 4.003